Adam May

What are we doing here folks? Can we please move on to diseases with at least an ounce of UNMET NEED? I promise there are people out there that could actually be helped with these billions of dollars. $ORKA https://t.co/dk6XQ2bu3y

Are these guys actually allergic to buying something roughly commercial stage in a new TA? All these obesity/CM revenues and NOTHING? Is there anyone out there who doesn’t think the stock would react favorably to late stage new TA M&A? WTF are these guys doing? $NVO https://t.co/sSULhqXCf3

Now probably my last point on $ABVX for today. “Management doesn’t seem like they have an offer” = massive selloff in spite of beyond blue sky data. Ok. Do we not recall this is the SAME management team who had the blinded blended UC induction data showing that their stock was about to 10x, yet ***they didn’t say a SINGLE thing about it***? Not one single word. Literally zero conferences, no earnings calls, NOTHING. Just a slide in the deck that, if you were enterprising enough, you could spend a few hours deriving the numbers by yourself. They were sitting on double Aces for >1,000% upside and didn’t say a word about it. Total silence. Now you’re trying to read tea leaves from the same guys about M&A? On top of that, the blinded/blended data were public information they were free to discuss (even though they never did)! M&A info is obviously blatant MNPI. Keep reading your tea leaves, for whatever they’re worth. Following the data instead of the noise is what has worked for me here so far.

$LLY execs re-reading the $NVS PR for the 10th time trying to see if they mentioned a MACE trend https://t.co/r0JWw8k9Rc

Legitimately curious what people think about $MRNA not having raised cash yet. What gives?

Not just the biggest $ move in the history of biotech, but also the biggest % move in the history of the S&P500! By a very wide margin too, and nearly 2 decades since the distant 2nd place had its day in the sun. Good to see data backing up that this $MRNA move was actually as crazy as it felt!

Alright I’m calling it - $MRNA at $160 is now up $40B on a small TAM trial readout that we already knew was working from data we *already* had earlier this year. This is the craziest single day biotech move I’ve ever seen. Gotta emphasize this - we LITERALLY ALREADY KNEW BEFORE TODAY that this trial was succeeding 😅

Ok what are the hot takes? Granted that we know essentially zero about how the deal would actually look, but still… Have at it! $AZN $BMY https://t.co/KJ4aexCNOR